Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Invitrogen Corporation - IVGN - Annual Report' returned 96 results - Page 1 of 5   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Invitrogen Corporation - Competitive Benchmarking Report   The Business Analysts Group, May 2007, Pages: 75 : Consolidated Balance Sheet of all the companies 3: Consolidated Profit and Loss Account of all the companies Invitrogen Corporation - Competitive Benchmarking Report Analysis of Invitrogen Corporation   Aruvian's R'search, Jan 2010, Pages: 60 is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more. A SWOT Framework Analysis of Invitrogen Corporation and its Cell/Tissue Culture Supplies - A Global Market Perspective   Bizacumen Inc., Nov 2009, Pages: 286 16 6. CORPORATE DEVELOPMENTS 17 Invitrogen Establishes Dedicated Business Unit for Cell Therapy 17 Invitrogen Signs Deal Premium Company Profile: Invitrogen Corporation   Datamonitor, Nov 2007, Pages: 50 Overview 47 Premium Company Profile: Invitrogen Corporation Drug Discovery Technologies - A Global Update of Market Trends & Opportunities   Bizacumen Inc., Nov 2009, Pages: 488 Discovery Collaborates with Illumina 47 Jubilant & Forest Enter into Partnership Deal 48 Invitrogen Corporation Signs Agreement with Emiliem to Screen Biotechnology Reagents - A Global Market Perspective   Bizacumen Inc., Nov 2009, Pages: 405 12 Protein Synthesis & Sequencing Reagents 12 6. CORPORATE DEVELOPMENTS 12 Invitrogen Plans to Acquire Proteomics - International Market Trends   Bizacumen Inc., Nov 2009, Pages: 320 Applied Biosystems (USA) 24 Bio-Rad Laboratories, Inc. (USA) 24 Dionex Corporation (USA) 25 GE Healthcare (United Kingdom) 25 Biacore Life Sciences (Sweden) 25 Invitrogen Corporation (USA) 25 Perkin The Top 60 Cancer Molecular Diagnostics Companies   Research Facts Ltd, March 2009, Pages: 124 Discovery Corporation Hologic Inc. Innogenetics NV Intergenetics, Inc. Invitrogen Corporation Ipsogen Kreatech Holding BV Matritech, Inc. Monogram Biosciences, Inc. Myriad Genetics, Inc. Nanosphere, Inc. Nor Next-Generation Immunoassays: A Market and Technical Analysis of Research Applications 07   Select Biosciences Ltd, Dec 2007, Pages: 177 Medical Diagnostics DiagnoSwiss SA GenTel Biosciences, Inc Gyros AB Hypromatrix, Inc Illumina, Inc Invitrogen Corporation Luminex Corporation Marligen Biosciences, Inc Merck Chemicals Ltd/EMD Chemicals, Inc RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011   Takeda Pacific, July 2007, Pages: 131 Pharmaceuticals, Inc. Benitec, Ltd. Cenix Bioscience GmbH CytRx Corporation Dharmacon, Inc. Integrated DNA Technologies, Inc. (IDT) Intradigm Corporation Intronn, Inc. Invitrogen Corporation Lentigen Corporation Life Technologies Corporation - SWOT Analysis   Datamonitor, April 2010, Pages: 30 profit of the company was $144.6 million in FY2009, compared t o a net profit of $5.7 million in FY2008. Scope of the Report - Provides all the crucial information on Life Technologies Corporation RNAi: Broad Application, Expansive Opportunity, 2nd Edition   Drug and Market Development Publishing, Jan 2005, Pages: 326 . Invitrogen Corporation MWG Biotech AG Laboratory Chemical Reagents - A Global Market Review   Bizacumen Inc., Nov 2009, Pages: 324 Review" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses. LABORATORY CHEMICAL REAGENTS The Global Bioinformatics Market: Market Size, Forecasts and Company Profiles   Business Insights, Sep 2009, Pages: 266 - CELERA GENOMIC CORPORATION , CLC BIO - DNASTAR, INC - GENE LOGIC - GENEGEO - GENEVA BIOINFORMATICS - ILLUMINA INC - INVITROGEN CORPORATION The Global Bioinformatics Market: Market Size, Forecasts Global Biotech Industry Monitor   ILogy Healthcare Solutions, Oct 2008, Pages: 16 Corporation - Millipore Corporation - Agilent technologies Inc - PDL BioPharma, Inc - Actelion Ltd - Sigma-Aldrich Corporation - Takara Bio Inc. - Crucell N.V. - Invitrogen Corporation - Amgen - Gilead Sciences Stem Cell Appoaches in Neurology and Psychiatry   NeuroInsights, Oct 2008, Pages: 170 An industry insider report on innovative research and development in stem cell technology for the central nervous system - Analyzes the scientific approaches and challenges to utilizing stem cells Optimizing Key Opinion Leader Relationships: Best Practices in KOL Management   Best Practices LLC, April 2009, Pages: 43 very quickly. I’ve found that large companies have difficulty adapting in a timely manner.” This research report examines how leading pharmaceutical companies approach KOL management. This report Bio-IT report   ILogy Healthcare Solutions, July 2008, Pages: 30 IBM Life Sciences Solutions Infosys Invitrogen Corporation Medidata Solutions  Microsoft Life Sciences MphasiS Oracle Persistent Systems Phase ForwardTM SAIC SAS Satyam SciQuest Symyx MDL Bio-IT report Company Financials: Life Technologies Corporation   Datamonitor, Jan 2010 relating to income statement, balance sheet, and cash flow statements. . Scope - Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency Electrophoresis Equipment & Supplies - A World Market Review   Bizacumen Inc., Nov 2009, Pages: 302 ) 15 Helena Laboratories Corporation (US) 15 Hoefer, Inc. (US) 15 Invitrogen (US Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   Next -   Last

		Top of page

All rights reserved. © Copyright 2010 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster